Published in J Nucl Med on May 01, 1992
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer. | NCT00414934
Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med (2010) 1.57
Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study. Eur J Nucl Med Mol Imaging (2008) 1.54
Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun (2015) 1.27
Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone. Bone (2008) 1.18
Synthesis of [18F]BODIPY: bifunctional reporter for hybrid optical/positron emission tomography imaging. Angew Chem Int Ed Engl (2012) 1.11
Antiretroviral tissue kinetics: in vivo imaging using positron emission tomography. Antimicrob Agents Chemother (2009) 1.11
Qualitative and quantitative ultrashort-TE MRI of cortical bone. NMR Biomed (2012) 1.06
Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases. J Nucl Med (2010) 1.04
The use of 18F-fluoride and 18F-FDG PET scans to assess fracture healing in a rat femur model. Eur J Nucl Med Mol Imaging (2007) 1.03
Imaging response to systemic therapy for bone metastases. Eur Radiol (2009) 0.99
Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine. Am J Nucl Med Mol Imaging (2015) 0.99
Dynamic 18F-fluoride small animal PET to noninvasively assess renal function in rats. Eur J Nucl Med Mol Imaging (2008) 0.96
Bone healing of severe acetabular defects after revision arthroplasty. Acta Orthop (2009) 0.94
A dual-radioisotope hybrid whole-body micro-positron emission tomography/computed tomography system reveals functional heterogeneity and early local and systemic changes following targeted radiation to the murine caudal skeleton. Calcif Tissue Int (2014) 0.94
Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review. Eur J Nucl Med Mol Imaging (2011) 0.93
Assessment of the metabolic activity of bone grafts with (18)F-fluoride PET. Eur J Nucl Med Mol Imaging (2004) 0.92
Bone metabolism after total hip revision surgery with impacted grafting: evaluation using H2 15O and [18F]fluoride PET; a pilot study. Mol Imaging Biol (2008) 0.89
Differences in regional bone metabolism at the spine and hip: a quantitative study using (18)F-fluoride positron emission tomography. Osteoporos Int (2012) 0.88
Noninvasive methods of measuring bone blood perfusion. Ann N Y Acad Sci (2010) 0.87
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics. Eur J Nucl Med Mol Imaging (2014) 0.87
Using cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsy. J Nucl Med (2009) 0.86
Estimation of regional bone metabolism from whole-body 18F-fluoride PET static images. Eur J Nucl Med Mol Imaging (2011) 0.85
Evaluation of bone remodeling with (18)F-fluoride and correlation with the glucose metabolism measured by (18)F-FDG in lumbar spine with time in an experimental nude rat model with osteoporosis using dynamic PET-CT. Am J Nucl Med Mol Imaging (2013) 0.85
Quantification of skeletal blood flow and fluoride metabolism in rats using PET in a pre-clinical stress fracture model. Mol Imaging Biol (2012) 0.85
Precision of ¹⁸F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism. Osteoporos Int (2012) 0.84
Bone metabolic activity in hyperostosis cranialis interna measured with 18F-fluoride PET. Eur J Nucl Med Mol Imaging (2010) 0.84
In vivo measurements of blood flow and bone metabolism in osteoarthritis. Rheumatol Int (2012) 0.84
Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET/CT in castrate resistant prostate cancer patients. Am J Nucl Med Mol Imaging (2015) 0.82
Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score. Int J Cardiovasc Imaging (2013) 0.82
Characterization of bone perfusion by dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography in the Dunkin-Hartley guinea pig model of advanced osteoarthritis. J Orthop Res (2014) 0.81
Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases. Clin Genitourin Cancer (2014) 0.81
Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion. Bone (2010) 0.80
(18)F Sodium Fluoride PET/CT in Patients with Prostate Cancer: Quantification of Normal Tissues, Benign Degenerative Lesions, and Malignant Lesions. World J Nucl Med (2016) 0.80
Nitric oxide-mediated vasodilation increases blood flow during the early stages of stress fracture healing. J Appl Physiol (1985) (2013) 0.80
Bone positron emission tomography with or without CT is more accurate than bone scan for detection of bone metastasis. Korean J Radiol (2013) 0.79
Time course of bone metabolism at the residual ridge beneath dentures observed using ¹⁸F-fluoride positron emission computerized-tomography/computed tomography (PET/CT). Ann Nucl Med (2012) 0.79
Analysis of bone mineralization on uncemented femoral stems by [18F]-fluoride-PET: a randomized clinical study of 16 hips in 8 patients. Acta Orthop (2013) 0.79
Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women. Osteoporos Int (2011) 0.79
Age-related changes in pre- and postmenopausal women investigated with 18F-fluoride PET--a preliminary study. Skeletal Radiol (2011) 0.78
Contemporary approaches for imaging skeletal metastasis. Bone Res (2015) 0.78
Parametric Images in Assessing Bone Grafts Using Dynamic F-Fluoride PET. Int J Mol Imaging (2011) 0.78
Sodium 18F-fluoride PET/CT of bone, joint, and other disorders. Semin Nucl Med (2015) 0.77
Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET. Phys Med Biol (2015) 0.77
Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer. Nucl Med Commun (2015) 0.77
Treatment response evaluation with (18)F-FDG PET/CT and (18)F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation. Eur J Nucl Med Mol Imaging (2016) 0.77
(18)F-NaF PET/CT: EANM procedure guidelines for bone imaging. Eur J Nucl Med Mol Imaging (2015) 0.76
Enhancement of the Regenerative Potential of Anorganic Bovine Bone Graft Utilizing a Polyglutamate-Modified BMP2 Peptide with Improved Binding to Calcium-Containing Materials. Tissue Eng Part A (2015) 0.76
F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques. Korean J Radiol (2015) 0.76
(18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease. Calcif Tissue Int (2013) 0.76
Advances in multimodality molecular imaging of bone structure and function. Bonekey Rep (2012) 0.75
PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology. Curr Atheroscler Rep (2016) 0.75
(18)F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma. EJNMMI Res (2016) 0.75
Evaluation of a short dynamic (18)F-fluoride PET/CT scanning method to assess bone metabolic activity in spinal orthopedics. Ann Nucl Med (2015) 0.75
18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer. Medicine (Baltimore) (2016) 0.75
Can Spatiotemporal Fluoride ((18)F(-)) Uptake be Used to Assess Bone Formation in the Tibia? A Longitudinal Study Using PET/CT. Clin Orthop Relat Res (2017) 0.75
Positron emission tomography imaging of coronary atherosclerosis. Future Cardiol (2016) 0.75
PET imaging of the neurovascular interface in cerebrovascular disease. Nat Rev Neurol (2017) 0.75
Predictive value of [(18)F]-fluoride PET for monitoring bone remodeling in patients with orthopedic conditions treated with a Taylor spatial frame. Eur J Nucl Med Mol Imaging (2016) 0.75
GATE: a simulation toolkit for PET and SPECT. Phys Med Biol (2004) 7.88
PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med (2006) 6.02
Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol (1979) 5.83
V beta-specific stimulation of human T cells by staphylococcal toxins. Science (1989) 5.34
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Positron emission tomography study of human brain functional development. Ann Neurol (1987) 4.89
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem (1997) 4.61
A tabulated summary of the FDG PET literature. J Nucl Med (2001) 4.37
Fluorescent modification of adenosine-containing coenzymes. Biological activities and spectroscopic properties. Biochemistry (1972) 4.06
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med (1997) 3.59
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol (2001) 3.53
Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med (1999) 3.31
A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci U S A (2000) 3.28
The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci (1998) 3.24
Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr (1979) 3.18
The major facilitator superfamily. J Mol Microbiol Biotechnol (1999) 3.17
Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol (1980) 3.12
Fluorescent adenosine and cytidine derivatives. Biochem Biophys Res Commun (1972) 3.12
Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med (2001) 3.03
TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity (1997) 2.96
The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr (1994) 2.88
The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. J Biol Chem (1998) 2.80
Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci U S A (1999) 2.71
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med (1998) 2.68
Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg (1997) 2.68
Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry (2001) 2.67
Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry (1989) 2.67
TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell (1999) 2.64
Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med (1996) 2.60
Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med (1998) 2.58
Nanocrystallization during nanoindentation of a bulk amorphous metal alloy at room temperature. Science (2002) 2.42
Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci U S A (2000) 2.41
Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology (1997) 2.39
Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation (1996) 2.31
Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc Natl Acad Sci U S A (2001) 2.27
Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther (1999) 2.21
Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol (1990) 2.12
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med (2000) 2.10
Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn (1987) 2.03
Imaging transgene expression with radionuclide imaging technologies. Neoplasia (2000) 2.03
Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry (1987) 1.98
Application of annihilation coincidence detection to transaxial reconstruction tomography. J Nucl Med (1975) 1.97
Noninvasive methods for quantitating blood time-activity curves from mouse PET images obtained with fluorine-18-fluorodeoxyglucose. J Nucl Med (1998) 1.97
TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol (1999) 1.95
Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J Exp Med (2000) 1.93
Positron emission tomography: human brain function and biochemistry. Science (1985) 1.92
Mutations in the FIE and MEA genes that encode interacting polycomb proteins cause parent-of-origin effects on seed development by distinct mechanisms. Plant Cell (2000) 1.90
TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J Exp Med (2000) 1.90
A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology (1975) 1.87
Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc Natl Acad Sci U S A (2002) 1.85
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol (2002) 1.85
Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. J Cereb Blood Flow Metab (1998) 1.84
Perceptual correlates of neural representations evoked by odorant enantiomers. J Neurosci (2001) 1.81
Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science (1986) 1.81
Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation (1993) 1.81
Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation (1999) 1.80
Comparison of standard and gender-specific posterior-cruciate-retaining high-flexion total knee replacements: a prospective, randomised study. J Bone Joint Surg Br (2010) 1.80
8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med (2001) 1.80
Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol (1980) 1.78
Bone versus immune system. Nature (2000) 1.78
13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation (1989) 1.77
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol (1982) 1.77
Mutations in the Arabidopsis VAR2 locus cause leaf variegation due to the loss of a chloroplast FtsH protease. Plant J (2000) 1.76
Metabolic mapping of the brain's response to visual stimulation: studies in humans. Science (1981) 1.75
Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem (1999) 1.75
Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet (1999) 1.74
Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci (2001) 1.73
Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol (1982) 1.73
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci U S A (2000) 1.69